262 related articles for article (PubMed ID: 25684642)
21. The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials.
Preiss D; Campbell RT; Murray HM; Ford I; Packard CJ; Sattar N; Rahimi K; Colhoun HM; Waters DD; LaRosa JC; Amarenco P; Pedersen TR; Tikkanen MJ; Koren MJ; Poulter NR; Sever PS; Ridker PM; MacFadyen JG; Solomon SD; Davis BR; Simpson LM; Nakamura H; Mizuno K; Marfisi RM; Marchioli R; Tognoni G; Athyros VG; Ray KK; Gotto AM; Clearfield MB; Downs JR; McMurray JJ
Eur Heart J; 2015 Jun; 36(24):1536-46. PubMed ID: 25802390
[TBL] [Abstract][Full Text] [Related]
22. Novel extracellular matrix biomarkers as predictors of adverse outcome in chronic heart failure: association between biglycan and response to statin therapy in the CORONA trial.
Ueland T; Aukrust P; Nymo SH; Kjekshus J; McMurray JJ; Wikstrand J; Block D; Zaugg C; Gullestad L
J Card Fail; 2015 Feb; 21(2):153-9. PubMed ID: 25451704
[TBL] [Abstract][Full Text] [Related]
23. Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).
Ridker PM; MacFadyen JG; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):616-23. PubMed ID: 20031900
[TBL] [Abstract][Full Text] [Related]
24. Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial.
Maggioni AP; Fabbri G; Lucci D; Marchioli R; Franzosi MG; Latini R; Nicolosi GL; Porcu M; Cosmi F; Stefanelli S; Tognoni G; Tavazzi L;
Eur Heart J; 2009 Oct; 30(19):2327-36. PubMed ID: 19717850
[TBL] [Abstract][Full Text] [Related]
25. Cancer in chronic heart failure patients in the GISSI-HF trial.
Ameri P; Canepa M; Luigi Nicolosi G; Marchioli R; Latini R; Tavazzi L; Maggioni AP;
Eur J Clin Invest; 2020 Sep; 50(9):e13273. PubMed ID: 32406516
[TBL] [Abstract][Full Text] [Related]
26. Statin therapy and clinical outcomes in myocardial infarction patients complicated by acute heart failure: insights from the EPHESUS trial.
Dobre D; Rossignol P; Murin J; Parkhomenko A; Lamiral Z; Krum H; van Veldhuisen DJ; Pitt B; Zannad F
Eur J Heart Fail; 2013 Feb; 15(2):221-7. PubMed ID: 22872593
[TBL] [Abstract][Full Text] [Related]
27. Soluble glycoprotein 130 predicts fatal outcomes in chronic heart failure: analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
Askevold ET; Nymo S; Ueland T; Gravning J; Wergeland R; Kjekshus J; Yndestad A; Cleland JG; McMurray JJ; Aukrust P; Gullestad L
Circ Heart Fail; 2013 Jan; 6(1):91-8. PubMed ID: 23230311
[TBL] [Abstract][Full Text] [Related]
28. CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trials.
Ueland T; Nymo SH; Latini R; McMurray JJ; Kjekshus J; Yndestad A; Fucili A; Grosu A; Masson S; Maggioni AP; Gullestad L; Aukrust P; ;
Eur J Heart Fail; 2013 Jul; 15(7):747-55. PubMed ID: 23487539
[TBL] [Abstract][Full Text] [Related]
29. Exploring new indications for statins beyond atherosclerosis: Successes and setbacks.
Waters DD
J Cardiol; 2010 Mar; 55(2):155-62. PubMed ID: 20206067
[TBL] [Abstract][Full Text] [Related]
30. [The role of statins in the treatment of heart failure].
Eren M
Turk Kardiyol Dern Ars; 2009 Oct; 37(7):501-11. PubMed ID: 20098048
[TBL] [Abstract][Full Text] [Related]
31. The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
Gullestad L; Ueland T; Kjekshus J; Nymo SH; Hulthe J; Muntendam P; McMurray JJ; Wikstrand J; Aukrust P
Am Heart J; 2012 Dec; 164(6):878-83. PubMed ID: 23194488
[TBL] [Abstract][Full Text] [Related]
32. Rosuvastatin added to standard heart failure therapy improves cardiac remodelling in heart failure rats with preserved ejection fraction.
Gómez-Garre D; González-Rubio ML; Muñoz-Pacheco P; Caro-Vadillo A; Aragoncillo P; Fernández-Cruz A
Eur J Heart Fail; 2010 Sep; 12(9):903-12. PubMed ID: 20601374
[TBL] [Abstract][Full Text] [Related]
33. Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial.
Marchioli R; Levantesi G; Silletta MG; Barlera S; Bernardinangeli M; Carbonieri E; Cosmi F; Franzosi MG; Latini R; Lucci D; Maggioni AP; Moretti L; Nicolosi GL; Porcu M; Rossi MG; Tognoni G; Tavazzi L;
Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):735-48. PubMed ID: 19589110
[TBL] [Abstract][Full Text] [Related]
34. [Are the guidelines correct? Should all patients with coronary heart disease or diabetes be treated with a statin?].
Pöss J; Böhm M; Laufs U
Med Klin (Munich); 2009 Jan; 104(1):74-8. PubMed ID: 19142597
[TBL] [Abstract][Full Text] [Related]
35. Circulating microRNA-132 levels improve risk prediction for heart failure hospitalization in patients with chronic heart failure.
Masson S; Batkai S; Beermann J; Bär C; Pfanne A; Thum S; Magnoli M; Balconi G; Nicolosi GL; Tavazzi L; Latini R; Thum T
Eur J Heart Fail; 2018 Jan; 20(1):78-85. PubMed ID: 29027324
[TBL] [Abstract][Full Text] [Related]
36. Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis.
Savarese G; Gotto AM; Paolillo S; D'Amore C; Losco T; Musella F; Scala O; Marciano C; Ruggiero D; Marsico F; De Luca G; Trimarco B; Perrone-Filardi P
J Am Coll Cardiol; 2013 Dec; 62(22):2090-9. PubMed ID: 23954343
[TBL] [Abstract][Full Text] [Related]
37. Association between use of statins and outcomes in heart failure with reduced ejection fraction: prospective propensity score matched cohort study of 21 864 patients in the Swedish Heart Failure Registry.
Alehagen U; Benson L; Edner M; Dahlström U; Lund LH
Circ Heart Fail; 2015 Mar; 8(2):252-60. PubMed ID: 25575580
[TBL] [Abstract][Full Text] [Related]
38. Who does not need a statin: too late in end-stage renal disease or heart failure?
Laufs U; Custodis F; Böhm M
Postgrad Med J; 2009 Apr; 85(1002):187-9. PubMed ID: 19417167
[TBL] [Abstract][Full Text] [Related]
39. Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure.
Horwich TB; MacLellan WR; Fonarow GC
J Am Coll Cardiol; 2004 Feb; 43(4):642-8. PubMed ID: 14975476
[TBL] [Abstract][Full Text] [Related]
40. Fatigue as a predictor of outcome in patients with heart failure: analysis of CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).
Perez-Moreno AC; Jhund PS; Macdonald MR; Petrie MC; Cleland JG; Böhm M; van Veldhuisen DJ; Gullestad L; Wikstrand J; Kjekshus J; Lewsey JD; McMurray JJ
JACC Heart Fail; 2014 Apr; 2(2):187-97. PubMed ID: 24720928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
